Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry

RATIONALE: Cannabis-based medicinal products (CBMPs) have been identified as novel therapeutics for generalised anxiety disorder (GAD) based on pre-clinical models; however, there is a paucity of high-quality evidence on their effectiveness and safety. OBJECTIVES: This study aimed to evaluate the cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Rifkin-Zybutz, Raphael, Erridge, Simon, Holvey, Carl, Coomber, Ross, Gaffney, Jessica, Lawn, Will, Barros, Daniela, Bhoskar, Urmila, Mwimba, Gracia, Praveen, Kavita, Symeon, Chris, Sachdeva-Mohan, Simmi, Rucker, James J, Sodergren, Mikael H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349732/
https://www.ncbi.nlm.nih.gov/pubmed/37314478
http://dx.doi.org/10.1007/s00213-023-06399-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349732/
https://www.ncbi.nlm.nih.gov/pubmed/37314478
http://dx.doi.org/10.1007/s00213-023-06399-3

Ejemplares similares